Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma

• Prif Awduron: Yosuke Shibata (Awdur), Takeshi Kishida (Awdur), Taku Kouro (Awdur), Feifei Wei (Awdur), Yuka Igarashi (Awdur), Hidetomo Himuro (Awdur), Takeaki Noguchi (Awdur), Mitsuyuki Koizumi (Awdur), Takahisa Suzuki (Awdur), Kimito Osaka (Awdur), Yusuke Saigusa (Awdur), Tetsuro Sasada (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Introduction: This study aimed to identify immune mediators, including cytokines, chemokines, and growth factors, in the plasma for predicting treatment efficacy and immune-related adverse events (irAEs) in advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICIs).Methods:...